Skip to main content
  • Saved

made a Post

Regulation of the tumor immune microenvironment and vascular normalization in TNBC murine models by a novel peptide

Regulation of the tumor immune microenvironment and vascular normalization in TNBC murine models by a novel peptide

Source :

https://www.tandfonline.com/doi/full/10.1080/2162402X.2020.1760685

ABSTRACT ABSTRACT Triple-negative breast cancer (TNBC) is a highly metastatic and aggressive disease with limited treatment options. Recently, the combination of the immune checkpoint inhibitor (ICI) atezolizumab (anti-PD-L1) with nab-paclitaxel was approved following a clinical trial that showed response rates in at least 43% of patients.